Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome

American Journal of Pathology

Volumn 179, Issue 3, 2011, Pages 1129-1137

  Swarts, Dorian R A ^a   Claessen, Sandra M H ^a   Jonkers, Yvonne M H ^a,g   Van Suylen, Robert Jan ^a   Dingemans, Anne Marie C ^a   De Herder, Wouter W ^b   De Krijger, Ronald R ^b   Smit, Egbert F ^c   Thunnissen, Frederik B J M ^c   Seldenrijk, Cornelis A ^d   Vink, Aryan ^e   Perren, Aurel ^g   Ramaekers, Frans C S ^a,f   Speel, Ernst Jan M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY OF BERN   (Switzerland)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL LUNG CARCINOID; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOID; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 1P; CHROMOSOME 2Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TELOMERE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; CHROMOSOMES, HUMAN, PAIR 11; DIPLOIDY; FEMALE; GENE DELETION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; YOUNG ADULT;

EID: 80052863475     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.05.028     Document Type: Article

References (54)

1. M.B. Beasley, F.B. Thunnissen, Ph.S. Hasleton, M. Barbareschi, B. Pugatch, K. Geisinger, E. Brambilla, A. Gazdar, and W.D. Travis Carcinoid Tumour WD W.D. Travis, E. Brambilla, H.K. Muller-Harmelink, C.C. Harris, Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart 2004 IARC Press Lyon, France 59 62
2. W.D. Travis Advances in neuroendocrine lung tumors Ann Oncol 21 Suppl 7 2010 vii65 vii71
3. D. Granberg, B. Eriksson, E. Wilander, P. Grimfjard, M.L. Fjallskog, K. Oberg, and B. Skogseid Experience in treatment of metastatic pulmonary carcinoid tumors Ann Oncol 12 2001 1383 1391 (Pubitemid 33100242)
4. M.B. Beasley, F.B. Thunnissen, E. Brambilla, P. Hasleton, R. Steele, S.P. Hammar, T.V. Colby, M. Sheppard, Y. Shimosato, M.N. Koss, R. Falk, and W.D. Travis Pulmonary atypical carcinoid: predictors of survival in 106 cases Hum Pathol 31 2000 1255 1265
5. E. Lim, P. Goldstraw, A.G. Nicholson, W.D. Travis, J.R. Jett, P. Ferolla, J. Bomanji, V.W. Rusch, H. Asamura, B. Skogseid, E. Baudin, M. Caplin, D. Kwekkeboom, E. Brambilla, and J. Crowley Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007 J Thorac Oncol 3 2008 1194 1201
6. D. Granberg, E. Wilander, K. Oberg, and B. Skogseid Prognostic markers in patients with typical bronchial carcinoid tumors J Clin Endocrinol Metab 85 2000 3425 3430
7. E. Brambilla, A. Negoescu, S. Gazzeri, S. Lantuejoul, D. Moro, C. Brambilla, and J.L. Coll Apoptosis-related factors p53, BclII, and Bax in neuroendocrine lung tumors Am J Pathol 149 1996 1941 1952 (Pubitemid 26415213)
8. M.B. Beasley, S. Lantuejoul, S. Abbondanzo, W.S. Chu, P.S. Hasleton, W.D. Travis, and E. Brambilla The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung Hum Pathol 34 2003 136 142 (Pubitemid 36258804)
9. D.R. Lohmann, B. Fesseler, B. Putz, U. Reich, J. Bohm, H. Prauer, P.H. Wunsch, and H. Hofler Infrequent mutations of the p53 gene in pulmonary carcinoid tumors Cancer Res 53 1993 5797 5801 (Pubitemid 23360290)
10. O.B. Rickman, P.K. Vohra, B. Sanyal, J.A. Vrana, M.C. Aubry, D.A. Wigle, and C.F. Thomas Analysis of ErbB receptors in pulmonary carcinoid tumors Clin Cancer Res 15 2009 3315 3324
11. L.V. Debelenko, E. Brambilla, S.K. Agarwal, J.I. Swalwell, M.B. Kester, I.A. Lubensky, Z. Zhuang, S.C. Guru, P. Manickam, S.E. Olufemi, S.C. Chandrasekharappa, J.S. Crabtree, Y.S. Kim, C. Heppner, A.L. Burns, A.M. Spiegel, S.J. Marx, L.A. Liotta, F.S. Collins, W.D. Travis, and M.R. Emmert-Buck Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung Hum Mol Genet 6 1997 2285 2290 (Pubitemid 27501081)
12. B. Görtz, J. Roth, A. Krahenmann, R.R. de Krijger, S. Muletta-Feurer, K. Rutimann, P. Saremaslani, E.J. Speel, P.U. Heitz, and P. Komminoth Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms Am J Pathol 154 1999 429 436 (Pubitemid 29094093)
13. G. Johnen, M. Krismann, M. Jaworska, and K.M. Muller [CGH findings in neuroendocrine tumours of the lung] German. Pathologe 24 2003 303 307 (Pubitemid 36890043)
14. S. Petzmann, R. Ullmann, H. Klemen, H. Renner, and H.H. Popper Loss of heterozygosity on chromosome arm 11q in lung carcinoids Hum Pathol 32 2001 333 338 (Pubitemid 32246809)
15. S. Petzmann, R. Ullmann, I. Halbwedl, and H.H. Popper Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study Virchows Arch 445 2004 151 159 (Pubitemid 39215546)
16. A.K. Walch, H.F. Zitzelsberger, M.M. Aubele, A.E. Mattis, M. Bauchinger, S. Candidus, H.W. Prauer, M. Werner, and H. Hofler Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization Am J Pathol 153 1998 1089 1098 (Pubitemid 28465832)
17. J. Zhao, R.R. de Krijger, D. Meier, E.J. Speel, P. Saremaslani, S. Muletta-Feurer, C. Matter, J. Roth, P.U. Heitz, and P. Komminoth Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis Am J Pathol 157 2000 1431 1438
18. D.H. Schussheim, M.C. Skarulis, S.K. Agarwal, W.F. Simonds, A.L. Burns, A.M. Spiegel, and S.J. Marx Multiple endocrine neoplasia type 1: new clinical and basic findings Trends Endocrinol Metab 12 2001 173 178 (Pubitemid 33713559)
19. J. Knijnenburg, Mv.D. Burg, H.J. Tanke, and K. Szuhai Optimized amplification and fluorescent labeling of small cell samples for genomic array-CGH Cytometry A 71 2007 585 591 (Pubitemid 47221720)
20. Y.M. Jonkers, S.M. Claessen, T. Feuth, A.G. van Kessel, F.C. Ramaekers, J.A. Veltman, and E.J. Speel Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis J Pathol 210 2006 450 458 (Pubitemid 44830605)
21. Y.M. Jonkers, S.M. Claessen, A. Perren, A.M. Schmitt, L.J. Hofland, W. de Herder, R.R. de Krijger, A.A. Verhofstad, A.R. Hermus, J.A. Kummer, B. Skogseid, M. Volante, A.C. Voogd, F.C. Ramaekers, and E.J. Speel DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients Endocr Relat Cancer 14 2007 769 779 (Pubitemid 350074065)
22. Y.M. Jonkers, S.M. Claessen, A. Perren, S. Schmid, P. Komminoth, A.A. Verhofstad, L.J. Hofland, R.R. de Krijger, P.J. Slootweg, F.C. Ramaekers, and E.J. Speel Chromosomal instability predicts metastatic disease in patients with insulinomas Endocr Relat Cancer 12 2005 435 447 (Pubitemid 40896457)
23. W.J. Kent, C.W. Sugnet, T.S. Furey, K.M. Roskin, T.H. Pringle, A.M. Zahler, and D. Haussler The human genome browser at UCSC Genome Res 12 2002 996 1006 (Pubitemid 34662293)
24. S.C. Chandrasekharappa, S.C. Guru, P. Manickam, S.E. Olufemi, F.S. Collins, M.R. Emmert-Buck, L.V. Debelenko, Z. Zhuang, I.A. Lubensky, L.A. Liotta, J.S. Crabtree, Y. Wang, B.A. Roe, J. Weisemann, M.S. Boguski, S.K. Agarwal, M.B. Kester, Y.S. Kim, C. Heppner, Q. Dong, A.M. Spiegel, A.L. Burns, and S.J. Marx Positional cloning of the gene for multiple endocrine neoplasia-type 1 Science 276 1997 404 407
25. M. van Asseldonk, M. Schepens, D. de Bruijn, B. Janssen, G. Merkx, and A. Geurts van Kessel Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints Genomics 66 2000 35 42 (Pubitemid 30347169)
26. E.J. Speel, J. Herbergs, F.C. Ramaekers, and A.H. Hopman Combined immunocytochemistry and fluorescence in situ hybridization for simultaneous tricolor detection of cell cycle, genomic, and phenotypic parameters of tumor cells J Histochem Cytochem 42 1994 961 966 (Pubitemid 24198456)
27. P.D. Leotlela, A. Jauch, H. Holtgreve-Grez, and R.V. Thakker Genetics of neuroendocrine and carcinoid tumours Endocr Relat Cancer 10 2003 437 450 (Pubitemid 38094880)
28. S.D. Finkelstein, T. Hasegawa, T. Colby, and S.A. Yousem 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets: a microdissection-based genotyping approach useful in clinical practice Am J Pathol 155 1999 633 640 (Pubitemid 29370413)
29. D.H. Kim, Y. Nagano, I.S. Choi, J.A. White, J.C. Yao, and A. Rashid Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors Genes Chromosomes Cancer 47 2008 84 92 (Pubitemid 350191467)
30. A. Warth, E. Herpel, S. Krysa, H. Hoffmann, P.A. Schnabel, P. Schirmacher, G. Mechtersheimer, and H. Blaker Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential Exp Mol Med 41 2009 349 353
31. M.G. Arrigoni, L.B. Woolner, and P.E. Bernatz Atypical carcinoid tumors of the lung J Thorac Cardiovasc Surg 64 1972 413 421
32. J. Voortman, J.H. Lee, J.K. Killian, M. Suuriniemi, Y. Wang, M. Lucchi, W.I. Smith Jr, P. Meltzer, Y. Wang, and G. Giaccone Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors Proc Natl Acad Sci USA 107 2010 13040 13045
33. C. Guo, P.S. White, M.J. Weiss, M.D. Hogarty, P.M. Thompson, D.O. Stram, R. Gerbing, K.K. Matthay, R.C. Seeger, G.M. Brodeur, and J.M. Maris Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas Oncogene 18 1999 4948 4957 (Pubitemid 29425301)
34. R. Spitz, B. Hero, T. Simon, and F. Berthold Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma Clin Cancer Res 12 2006 3368 3373
35. J.R. Dunn, D. Panutsopulos, M.W. Shaw, J. Heighway, R. Dormer, E.N. Salmo, S.G. Watson, J.K. Field, and T. Liloglou METH-2 silencing and promoter hypermethylation in NSCLC Br J Cancer 91 2004 1149 1154 (Pubitemid 39336255)
36. J.A. Tsou, J.S. Galler, K.D. Siegmund, P.W. Laird, S. Turla, W. Cozen, J.A. Hagen, M.N. Koss, and I.A. Laird-Offringa Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma Mol Cancer 6 2007 70
37. P.P. Anglim, J.S. Galler, M.N. Koss, J.A. Hagen, S. Turla, M. Campan, D.J. Weisenberger, P.W. Laird, K.D. Siegmund, and I.A. Laird-Offringa Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer Mol Cancer 7 2008 62
38. G.C. Sellar, K.P. Watt, G.J. Rabiasz, E.A. Stronach, L. Li, E.P. Miller, C.E. Massie, J. Miller, B. Contreras-Moreira, D. Scott, I. Brown, A.R. Williams, P.A. Bates, J.F. Smyth, and H. Gabra OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer Nat Genet 34 2003 337 343 (Pubitemid 36792869)
39. H. Dannenberg, W.N. Dinjens, M. Abbou, U.H. Van, B.K. Pauw, D. Mouwen, W.J. Mooi, and R.R. de Krijger Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma Clin Cancer Res 8 2002 2061 2066 (Pubitemid 34753574)
40. K. Ando, M. Ohira, T. Ozaki, A. Nakagawa, K. Akazawa, Y. Suenaga, Y. Nakamura, T. Koda, T. Kamijo, Y. Murakami, and A. Nakagawara Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation Int J Cancer 123 2008 2087 2094
41. B. Austen, A. Skowronska, C. Baker, J.E. Powell, A. Gardiner, D. Oscier, A. Majid, M. Dyer, R. Siebert, A.M. Taylor, P.A. Moss, and T. Stankovic Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion J Clin Oncol 25 2007 5448 5457 (Pubitemid 350232222)
42. A. Yokoyama, Z. Wang, J. Wysocka, M. Sanyal, D.J. Aufiero, I. Kitabayashi, W. Herr, and M.L. Cleary Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression Mol Cell Biol 24 2004 5639 5649 (Pubitemid 38787950)
43. C.M. Hughes, O. Rozenblatt-Rosen, T.A. Milne, T.D. Copeland, S.S. Levine, J.C. Lee, D.N. Hayes, K.S. Shanmugam, A. Bhattacharjee, C.A. Biondi, G.F. Kay, N.K. Hayward, J.L. Hess, and M. Meyerson Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus Mol Cell 13 2004 587 597 (Pubitemid 38299385)
44. M.C. Kottemann, and A.E. Bale Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model DNA Repair (Amst) 8 2009 944 952
45. T.A. Milne, C.M. Hughes, R. Lloyd, Z. Yang, O. Rozenblatt-Rosen, Y. Dou, R.W. Schnepp, C. Krankel, V.A. Livolsi, D. Gibbs, X. Hua, R.G. Roeder, M. Meyerson, and J.L. Hess Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors Proc Natl Acad Sci USA 102 2005 749 754 (Pubitemid 40282737)
46. N. Brookman-Amissah, C. Duchesnes, M.P. Williamson, Q. Wang, A. Ahmed, M.R. Feneley, A. Mackay, A. Freeman, K. Fenwick, M. Iravani, B. Weber, A. Ashworth, and J.R. Masters Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH Prostate Cancer Prostatic Dis 8 2005 335 343 (Pubitemid 43078168)
47. Y. Hosomi, A. Gemma, Y. Hosoya, M. Nara, T. Okano, K. Takenaka, A. Yoshimura, K. Koizumi, K. Shimizu, and S. Kudoh Somatic mutation of the caspase-5 gene in human lung cancer Int J Mol Med 12 2003 443 446
48. M. Lamkanfi, M. Kalai, and P. Vandenabeele Caspase-12: an overview Cell Death Differ 11 2004 365 368 (Pubitemid 38489413)
49. M. Lamkanfi, G. Denecker, M. Kalai, K. D'hondt, A. Meeus, W. Declercq, X. Saelens, and P. Vandenabeele INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation J Biol Chem 279 2004 51729 51738 (Pubitemid 39656538)
50. Y.H. Soung, E.G. Jeong, C.H. Ahn, S.S. Kim, S.Y. Song, N.J. Yoo, and S.H. Lee Mutational analysis of caspase 1, 4, and 5 genes in common human cancers Hum Pathol 39 2008 895 900
51. T.K. Zirbes, J. Lorenzen, S.E. Baldus, S.P. Moenig, U. Wolters, A. Ottlik, J. Thiele, A.H. Holscher, and H.P. Dienes Apoptosis and expression of bcl-2 protein are inverse factors influencing tumour cell turnover in primary carcinoid tumours of the lung Histopathology 33 1998 123 128 (Pubitemid 28387021)
52. K. Inamura, R. Furuta, Y. Satoh, T. Shirakawa, S. Okumura, K. Nakagawa, M. Fujiwara, E. Tsuchiya, and Y. Ishikawa Loss of chromosome 13q is associated with malignant potential in pulmonary carcinoids Cancer Genomics Proteomics 3 2006 39 46
53. A.O. Chan, S.G. Kim, A. Bedeir, J.P. Issa, S.R. Hamilton, and A. Rashid CpG island methylation in carcinoid and pancreatic endocrine tumors Oncogene 22 2003 924 934 (Pubitemid 36255828)
54. W.X. Peng, T. Shibata, H. Katoh, A. Kokubu, Y. Matsuno, H. Asamura, R. Tsuchiya, Y. Kanai, F. Hosoda, T. Sakiyama, M. Ohki, I. Imoto, J. Inazawa, and S. Hirohashi Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung Cancer Sci 96 2005 661 667 (Pubitemid 41723542)